Details
Stereochemistry | ACHIRAL |
Molecular Formula | C22H25N3O4 |
Molecular Weight | 395.4516 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(CN(CC2)C3=NC4=CC(OC)=C(OC)C=C4C(N)=C3)C=C1OC
InChI
InChIKey=ANZIISNSHPKVRV-UHFFFAOYSA-N
InChI=1S/C22H25N3O4/c1-26-18-7-13-5-6-25(12-14(13)8-19(18)27-2)22-10-16(23)15-9-20(28-3)21(29-4)11-17(15)24-22/h7-11H,5-6,12H2,1-4H3,(H2,23,24)
Molecular Formula | C22H25N3O4 |
Molecular Weight | 395.4516 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/10845763
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10845763
Abanoquil (UK-52,046), an antiarrhythmic drug, is an alpha 1-adrenoceptor antagonist, has been studied for the treatment of erectile dysfunction.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094251 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10845763 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1349492
single oral doses of abanoquil 0.25, 0.5 and 1 mg
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:50:36 GMT 2023
by
admin
on
Sat Dec 16 17:50:36 GMT 2023
|
Record UNII |
F738MWY53L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29713
Created by
admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
ABANOQUIL
Created by
admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
|
PRIMARY | |||
|
F738MWY53L
Created by
admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
|
PRIMARY | |||
|
6761
Created by
admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
|
PRIMARY | |||
|
C72566
Created by
admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
|
PRIMARY | |||
|
C058534
Created by
admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
|
PRIMARY | |||
|
100000082323
Created by
admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
|
PRIMARY | |||
|
164089
Created by
admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
|
PRIMARY | |||
|
CHEMBL324090
Created by
admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
|
PRIMARY | |||
|
DTXSID40238163
Created by
admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
|
PRIMARY | |||
|
90402-40-7
Created by
admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
|
PRIMARY | |||
|
SUB07358MIG
Created by
admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |